Antibody-based therapeutics and vaccines are essential to combat COVID-19 morbidity and
mortality after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. …

Colonization of the human small intestine by Vibrio cholerae is an essential step in pathogenesis
that requires the type IV toxin-coregulated pilus (TCP). To date, three functions of TCP …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
stresses the continued need for next-generation vaccines that confer broad protection …

Lineage-based vaccine design is an attractive approach for eliciting broadly neutralizing
antibodies (bNAbs) against HIV-1. However, most bNAb lineages studied to date have features …

The need for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) next-generation
vaccines has been highlighted by the rise of variants of concern (VoCs) and the long-term …

Background. Serious non-AIDS events cause substantial disease and death despite human
immunodeficiency virus (HIV) suppression with antiretroviral therapy (ART). Biomarkers of …

Prevention of viral escape and increased coverage against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) variants of concern require therapeutic monoclonal …

Objective: To evaluate differences in soluble inflammatory markers between chronically HIV-infected
men and women, with or without cognitive impairment, and in response to treatment…

Despite rapid and ongoing vaccine and therapeutic development, SARS-CoV-2 continues
to evolve and evade, presenting a need for next-generation diverse therapeutic modalities. …

Purpose The objective of this study is to evaluate the feasibility of using coated microneedles
to deliver vaccines into the oral cavity to induce systemic and mucosal immune responses. …